Viewing Study NCT01106066


Ignite Creation Date: 2025-12-24 @ 4:01 PM
Ignite Modification Date: 2026-01-02 @ 8:43 AM
Study NCT ID: NCT01106066
Status: TERMINATED
Last Update Posted: 2013-06-14
First Post: 2010-04-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I/II Study of Neoadjuvant Chemoradiotherapy With S-1/ Oxaliplatin in Patients With Gastric Cancer: Randomized Phase II Study of S-1/RT vs. S-1/Oxaliplatin/RT
Sponsor: Samsung Medical Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2008-06-013
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators